Publications by authors named "Matthieu Daugan"

Claim this Profile
S
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.
Glenn Hamonic, Elodie Pastural, Supriya Arora, Jocelyne Lew, Yun Cai, Matthieu Daugan

Vaccine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.
Mark Manak, Luc Gagnon, Steven Phay-Tran, Philipa Levesque-Damphousse, Aymeric Fabie, Matthieu Daugan

Lancet Microbe· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection.
Matthieu Daugan, Armstrong Murira, Barbara C Mindt, Amélie Germain, Esther Tarrab

Front Immunol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Separation of function between isotype switching and affinity maturation in vivo during acute immune responses and circulating autoantibodies in UNG-deficient mice.
Astrid Zahn, Matthieu Daugan, Shiva Safavi, David Godin, Cheolho Cheong

J Immunol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis